CD274 and hepatocellular carcinoma: These findings highlight the importance of dynamic evaluation of PD-L1 expression in identifying HCC patients who are suitable for triple therapy and supporting physicians to alter treatments as soon as possible for HCC patients who are unlikely to respond.